| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/22/1995 | EP0639076A1 Use of guanylate cyclase inhibitors in the treatment of shock |
| 02/22/1995 | EP0639075A1 Specific inhibition of dihydrofolate reductase and compounds therefor |
| 02/22/1995 | EP0639074A1 Anti-ischemic medicament |
| 02/22/1995 | EP0639073A1 Biologically active ureido derivatives useful as antimetastatic agents |
| 02/22/1995 | EP0639072A1 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration |
| 02/22/1995 | EP0639068A1 Acne treating composition |
| 02/22/1995 | EP0639055A1 Methods of treating obesity with purine related compounds |
| 02/22/1995 | EP0609394A4 Anti-explosion pads and their method of use. |
| 02/22/1995 | EP0526502B1 Phenolic amine depigmenting and antimelanoma agents |
| 02/22/1995 | EP0437563B1 Biologically active drug polymer derivatives |
| 02/22/1995 | CN1099038A 3-deoxy oligosaccharides, processes for preparing them and pharmaceutical compositions containing them |
| 02/22/1995 | CN1099035A Spirocyclic piperidine derivatives |
| 02/22/1995 | CN1099033A Pyrazolo|4,3-c¨pyridines, a process for their preparation and their use as serotonin reuptake inhibitors |
| 02/22/1995 | CN1099032A Derivative of benzoxazine, preparation and pharmaceutical application of same |
| 02/22/1995 | CN1098912A Carbohydrate for curing gonorrhea |
| 02/22/1995 | CN1098911A Compounded painkilling and anti inflammatory cream |
| 02/22/1995 | CN1098910A Compounded anti-cold inhalation using pseudo ephedrine |
| 02/22/1995 | CN1098909A Antioxidant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds |
| 02/22/1995 | CN1098908A Antioxidant neuroprotective use of, and method of treatment using hydroxycarbazole compounds |
| 02/22/1995 | CN1098907A Dry mix formulation for bisphosphonic acids |
| 02/22/1995 | CN1098906A Total alkanol for reducing blood-fat |
| 02/22/1995 | CN1098903A Derivative of 6,6-dimethyl-2-acylcyclohex-4-en-1,3-diones |
| 02/22/1995 | CN1027695C Heterocyclic-NMDA antagonists |
| 02/22/1995 | CN1027694C Method for manufacturing of N-methyl-D-aspartic acid |
| 02/21/1995 | USRE34865 Antibiotics |
| 02/21/1995 | US5391825 Adrenergic blocking agents; cardiovascular disorders; uregenital disorders |
| 02/21/1995 | US5391817 Biaryl phospholipase A2 inhibitors |
| 02/21/1995 | US5391800 Protecting hydroxyl groups of sphingosine, deprotecting C1, phosphorylating, deprotecting C3; free of L-threo isomer |
| 02/21/1995 | US5391776 Steroid derivatives |
| 02/21/1995 | US5391775 Process for production of diacetylrhein |
| 02/21/1995 | US5391766 Antiarthritic agents for rheumatoid, immunosuppressants; treating psoriasis, autoimmune diseases |
| 02/21/1995 | US5391761 Preparation of novel amido-alcohol derivatives and their therapeutic uses |
| 02/21/1995 | US5391758 Heterocyclic amide derivatives |
| 02/21/1995 | US5391755 Regulator of calcium homeostasis in animals; useful as therapeutic agent and treats malignancies |
| 02/21/1995 | US5391754 Oximination a tetrahydropyridin-3-aldehyde, alkylation with a halides, salt formation |
| 02/21/1995 | US5391753 Tumor inhibiting agents; useful for treating dermatological conditions and rheumatic illnesses |
| 02/21/1995 | US5391752 Oxidizing a cooled mixture of pyrmetazole and solvent to obtain omeprazole |
| 02/21/1995 | US5391751 Hypotensive, antiarrhythmia, antiasthmatic agents |
| 02/21/1995 | US5391746 Inhibitors of lentiviruses; deoxynojirimycin derivatives |
| 02/21/1995 | US5391742 2-(8-Azabicyclo(3.2.1)oct-8-yl)alkanols |
| 02/21/1995 | US5391732 Cardiotonic agents, hypotensive agents, antispasmodic agents |
| 02/21/1995 | US5391731 Pyrroloazepine derivatives |
| 02/21/1995 | US5391696 Polycondensates which contain tartaric acid derivatives, processes for their preparation and use thereof |
| 02/21/1995 | US5391577 N-phenylalkyl substituted α-amino carboxamide derivatives and process for their preparation |
| 02/21/1995 | US5391576 Method for treating and protecting the cerebral tissue against repercussions of cerebral ischaemia and cerebral infarctions |
| 02/21/1995 | US5391575 Administering mixture of phenylacetylglutamine and phenylacetic acid or their salts or derivatives |
| 02/21/1995 | US5391574 Antispasmodic agents |
| 02/21/1995 | US5391569 Treating osteoporosis, inflammatory disorders |
| 02/21/1995 | US5391568 Administering catechin-3-gallate |
| 02/21/1995 | US5391565 Oxazolidine dione derivatives |
| 02/21/1995 | US5391564 E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents |
| 02/21/1995 | US5391563 Administering specific iron chelator |
| 02/21/1995 | US5391560 Substituted carbamoylpyrazolines |
| 02/21/1995 | US5391559 Antiischemic agents; antihypoxic agents; antiedemic agents |
| 02/21/1995 | US5391558 2-(Imidazol-1-yl or 1H-1,2,4-triazol-1-yl)-2-(4-(hydroxyphenyl )-1,3-thiolan-2-ylidene)acetonitriles; topical |
| 02/21/1995 | US5391557 Administering substituted 2-phenyl-3-aroylbenzothiophenes; reduced side effects |
| 02/21/1995 | US5391556 Thrombin inhibitors |
| 02/21/1995 | US5391555 Administering 2-(4(2-quinolinyl-methoxy)-phenyl)-acetic acid derivatives; Crohn's disease |
| 02/21/1995 | US5391553 Increasing cholinergic functionin mammals |
| 02/21/1995 | US5391551 Method of lowering blood lipid levels |
| 02/21/1995 | US5391550 Compositions of matter and methods for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
| 02/21/1995 | US5391549 Cinnoline-3-carboxylic acid derivatives |
| 02/21/1995 | US5391547 Method using 5,10,15,20-tetrakis(4-carboxyphenyl)porphine for treating cancers of the lung |
| 02/21/1995 | US5391544 Cyathane derivatives and antimicrobial agents containing same |
| 02/21/1995 | US5391495 Using enzyme or microorganism catalyst |
| 02/21/1995 | US5391376 Method for preventing and treating cachexia |
| 02/21/1995 | US5391375 Impermeable cover layer, pressure sensitive adhesive reservoir layer containing basic polymer, softener, physostigmine solution in acid solvent |
| 02/21/1995 | US5391367 Antifungal nail solution |
| 02/21/1995 | CA2127938A1 Asymmetrically substituted diaminodicarboxylic acid derivatives and a process for their preparation |
| 02/21/1995 | CA2006144C Microbial process for the production of immunosuppressive antibiotics |
| 02/21/1995 | CA1334516C Process for preparing high-purity dermatan sulphate, and pharmaceutical compositions which contain it |
| 02/21/1995 | CA1334508C Method of inhibiting the activity of leukocyte derived cytokines |
| 02/19/1995 | CA2130291A1 Therapeutic uses of known ester and amide compounds |
| 02/19/1995 | CA2129906A1 Naphthalene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/19/1995 | CA2117503A1 Azoxycyanobenzodioxane derivatives |
| 02/17/1995 | CA2130132A1 Bile duct deterging composition and a method for deterging the bile duct |
| 02/17/1995 | CA2130044A1 Macrolides and the use thereof |
| 02/16/1995 | WO1995004746A1 Antiparasitic agents |
| 02/16/1995 | WO1995004741A1 Aza-5,5-fused heterocyclic acids as leukotriene antagonists |
| 02/16/1995 | WO1995004738A1 C-22 ring stabilized rapamycin derivatives |
| 02/16/1995 | WO1995004737A1 Condensed indole derivatives as 5-ht4-receptor antagonists |
| 02/16/1995 | WO1995004736A1 Process for the preparation of 9-amino camptothecin |
| 02/16/1995 | WO1995004735A1 Matrix metalloprotease inhibitors |
| 02/16/1995 | WO1995004734A1 Hydroisoquinoline derivatives |
| 02/16/1995 | WO1995004732A1 Oligopeptide antiretroviral agents |
| 02/16/1995 | WO1995004730A1 Benzopyrans and pharmaceutical compositions containing them |
| 02/16/1995 | WO1995004729A1 Amide derivatives as 5ht1d receptor antagonists |
| 02/16/1995 | WO1995004720A2 Gastrin and cck receptor ligands |
| 02/16/1995 | WO1995004714A1 Substituted kynurenines, a process for their preparation, and use as medicaments |
| 02/16/1995 | WO1995004713A1 2-aminoindans as selective dopamine d3 ligands |
| 02/16/1995 | WO1995004554A1 Low flux transdermal potent drug delivery system |
| 02/16/1995 | WO1995004549A1 Creating new capillary blood pools for practising bidirectional medicine |
| 02/16/1995 | WO1995004544A1 A method for sensitization of cancer cells for killer cell mediated lysis |
| 02/16/1995 | WO1995004538A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 02/16/1995 | WO1995004537A1 Cosmetic compositions |
| 02/16/1995 | WO1995004536A1 Antiglucocorticoid steroids for the treatment of anxiety disorders |
| 02/16/1995 | WO1995004535A1 Estrogenic compounds as anti-mitotic agents |
| 02/16/1995 | WO1995004534A1 Endothelin receptor antagonists |
| 02/16/1995 | WO1995004533A2 Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents |
| 02/16/1995 | WO1995004532A1 Substituted 2-aminotetralins |